FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

174 letters match. Newest first.

  1. Healwell Homeo Private Limited

    FDA warns Healwell Homeo over pest-infested drug storage and manufacturing violations.

    High risk
  2. Staska Pharmaceuticals, Inc.

    FDA warns Staska Pharmaceuticals, a Nebraska outsourcing facility, that sterile compounded drugs had contamination risks and labeling problems.

    High risk
  3. Amish Origins Management, LLC

    FDA warned Amish Origins over manufacturing quality failures and unapproved or misbranded OTC pain relief and lip balm products.

    High risk
  4. Anti L’Age

    FDA warned Anti L'Age over dietary supplements made without required manufacturing standards, records, quality controls, and proper labeling.

    Medium
  5. Wuxi Medical Instrument Factory Co., Ltd.

    FDA warns Wuxi Medical Instrument Factory over insanitary conditions and manufacturing failures for sterile drugs.

    High risk
  6. Excelvision Fareva

    Excelvision Fareva, a sterile drug manufacturer, was cited for inadequate mold/black-speck complaint investigations and aseptic contamination controls.

    High risk
  7. OSRX, Inc.

    OSRX, a Montana compounding facility, made sterile ophthalmic drugs under insanitary conditions with quality and labeling failures.

    High risk
  8. Dyno Manufacturing, Inc.

    Dyno Manufacturing’s OTC hand sanitizer and antibacterial soap drugs lacked raw-material identity testing and other required manufacturing controls.

    High risk
  9. Empower Clinic Services, LLC dba Empower Pharma

    FDA warns Empower Pharma over sterile drug manufacturing deficiencies, labeling, and unapproved compounded drugs after August 2024 inspection.

    High risk
  10. PMS4PMS, LLC

    FDA warns PMS4PMS of Clarence, NY, over CGMP failures and an unapproved menstrual cramp relief cream.

    High risk
  11. Nubratori, Inc. dba Nubratori Rx

    FDA cited Nubratori Rx, a sterile compounding outsourcing facility, for insanitary conditions and manufacturing quality failures that may contaminate its drug products.

    High risk
  12. Annovex Pharma, Inc.

    FDA warns outsourcing facility Annovex Pharma in Lorton, VA, over contaminated sterile drug production and missed FDA reports.

    High risk
  13. Advanced Pharmaceutical Technology

    FDA warns Advanced Pharmaceutical Technology over drug manufacturing quality failures, sterility controls, and unapproved drugs.

    High risk
  14. Neva Global Grup Sanayi Ic Ve Dis Ticaret Anonim Sirketi

    FDA warns Turkish OTC drug maker Neva Global over inadequate component testing, process validation, stability, and quality oversight.

    High risk
  15. Aspen Pharmacare Holdings Limited

    FDA warns Aspen subsidiary over sterile OTC drug manufacturing failures including impurity testing, aseptic practices, data integrity, and environmental monitoring.

    High risk
  16. Rite-Kem Incorporated

    FDA warned Rite-Kem over inadequate current good manufacturing practice testing of over-the-counter drugs, including hand sanitizers and antimicrobial products.

    High risk
  17. Right Value Drug Stores, LLC dba Carie Boyd Pharmaceuticals

    FDA warned outsourcing facility Carie Boyd Pharmaceuticals in Irving, TX that sterile drug production had airflow, media fill and contamination control failures.

    High risk
  18. ProRx, LLC

    FDA warns ProRx, LLC about insanitary sterile compounded-drug production and manufacturing-quality failures.

    High risk
  19. Marshalls Traditional Healthcare CC

    Marshalls Traditional Healthcare, an OTC drug maker in South Africa, lacked finished-product release testing and process validation.

    High risk
  20. Fagron Compounding Services, LLC dba Fagron Sterile Service

    FDA warns Fagron Sterile Services about unsafe sterile drug production and labeling problems at its Wichita facility.

    High risk
  21. Western Innovations, Inc.

    FDA warns Western Innovations over manufacturing-rule violations in Acetyl-glutathione supplements after Denver inspection.

    Medium
  22. Indoco Remedies Limited

    FDA warned Indoco Remedies over manufacturing quality failures at its Goa plant, including unreliable microbial testing and aseptic processing deficiencies.

    High risk
  23. Loyd Sanabria Hernandez dba Avicola Santa Fe

    FDA warns Puerto Rico shell egg farm Avicola Santa Fe over Salmonella prevention, testing, and registration failures.

    High risk
  24. Barohup Inc.

    Barohup Inc. lacked foreign supplier verification for imported foods and kept importing enoki mushrooms after a Listeria finding.

    High risk
  25. Colgate-Palmolive/Tom's of Maine, Inc.

    FDA cited Tom's of Maine for CGMP failures after finding objectionable microbes in water and toothpaste and inadequate complaint handling.

    High risk
  26. Armstrong County Memorial Hospital

    FDA warns Armstrong County Memorial Hospital review board over missing procedures and inadequate meeting minutes for drug research.

    Medium
  27. Analytical Food Laboratories, Inc.

    FDA warned contract testing lab Analytical Food Laboratories after inspection found unvalidated drug test methods and weak quality oversight.

    High risk
  28. Louisiana State University Health Science Center IRB

    FDA warns Louisiana State University Health Science Center IRB about missed continuing reviews and unreported study terminations for drug research.

    Medium
  29. Pacific Exchange Distributors LLC

    FDA warns importer Pacific Exchange Distributors it lacked a foreign supplier verification program for most imported foods.

    High risk
  30. Wittman Pharma, Inc.

    FDA warns Wittman Pharma, an OTC drug maker in Brooksville, Florida, that weak quality oversight and contaminated water make its products adulterated.

    High risk
  31. Kaylaan LLC

    FDA warns Kaylaan LLC that its fluoride toothpaste tablets were made without release testing, raw material identity testing, and adequate CGMP controls.

    High risk
  32. EyePoint Pharmaceuticals, Inc.

    FDA cited EyePoint Pharmaceuticals in Watertown, MA for manufacturing-quality violations affecting its YUTIQ eye implant, including inadequate investigations and process controls.

    High risk
  33. Txsyn Int. LLC

    FDA says Txsyn Int. repackaged dietary supplements without required manufacturing procedures and quality approval.

    Medium
  34. Central Admixture Pharmacy Services, Inc.

    FDA warns Central Admixture Pharmacy Services over sterile compounded drugs, contamination risks, and quality failures at its San Diego site.

    High risk
  35. La Parcela Produce LLC

    La Parcela Produce LLC lacked required U.S. importer food-safety records for imported cilantro, lettuce, poblano pepper, and jalapeno.

    Medium
  36. Greenfruit Avocados, LLC

    FDA warns Greenfruit Avocados after foreign supplier verification inspection found it did not verify avocado growers.

    Medium
  37. Max Chemical Inc.

    FDA warned Max Chemical Inc. in San Juan, Puerto Rico, that its OTC drug manufacturing violated CGMP, making its drugs adulterated.

    High risk
  38. ARG Laboratories, Inc.

    FDA found ARG Laboratories released failing over-the-counter drug lots, lacked manufacturing controls, and marketed two unapproved pain creams.

    High risk
  39. Art of Beauty Company, Inc.

    FDA warned Art of Beauty over manufacturing-rule violations in OTC hand sanitizer, including missing component and finished-product testing.

    High risk
  40. New Mexico Lions Sight Conservation Foundation, Inc. dba New Mexico Lions Eye Bank

    FDA warns New Mexico eye bank over distributing eye tissue from two donors with sepsis.

    High risk
  41. AKT Trading Inc.

    AKT Trading lacked required foreign supplier checks for imported mushrooms and bamboo shoots, FDA says.

    High risk
  42. Cosmetic Solutions, LLC

    FDA warns Cosmetic Solutions over manufacturing failures and unapproved OTC drugs at Boca Raton plant.

    High risk
  43. Genpro Imports & Export Inc.

    FDA warns Genpro Imports over missing FSVP records for imported produce and ginger.

    Medium
  44. Seatex, LLC

    FDA: Seatex made hand sanitizer on equipment also used for floor cleaner and skipped ingredient identity tests.

    High risk
  45. Pinnacle Labs of Tennessee, LLC dba Pinnacle BioLabs

    Pinnacle BioLabs sells a fecal blood test as a colon cancer screening test without FDA clearance and lacks complaint, CAPA and MDR procedures.

    High risk
  46. Master Paints & Chemicals Corp.

    FDA warned Master Paints & Chemicals Corp. over inadequate testing and quality oversight for OTC drugs including hand sanitizer.

    High risk
  47. FirstCham Co., Ltd.

    FDA warns FirstCham over current good manufacturing practice violations and misbranding of Soo'Ae hand sanitizing wipes.

    High risk
  48. Kilitch Healthcare India Limited

    FDA warns Kilitch Healthcare India over insanitary sterile drug manufacturing and falsified environmental monitoring data.

    High risk
  49. Zoet Poultry, Inc.

    Zoet Poultry's shell egg farm lacked an implemented Salmonella Enteritidis prevention plan and required environmental testing.

    High risk
  50. New York State Psychiatric Institute IRB

    FDA warned New York State Psychiatric Institute's review board it failed to report serious research problems and reviewed drug studies without required nonscientific member.

    High risk